CARDIOFLOW-B News

CARDIOFLOW-B: PROFIT FORECAST FOR THE FIRST HALF OF 2024 -SIGNIFICANT REDUCTION IN NET LOSS OFAPPROXIMATELY 63% TO 72%

Jul 24 09:18 ET

CARDIOFLOW-B: Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Jul 22 05:07 ET

CARDIOFLOW-B: Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Jul 22 05:02 ET

CARDIOFLOW-B: CONTINUING CONNECTED TRANSACTIONIN RELATION TOTHE 2024 KEWEI DISTRIBUTION FRAMEWORK AGREEMENTANDCONNECTED TRANSACTIONIN RELATION TO THE KEWEI LOAN AGREEMENT

Jul 19 10:50 ET

CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 5 04:30 ET

CARDIOFLOW-B: ESTIMATED INTERIM RESULTS FOR THE SIX MONTHS ENDEDJUNE 30, 2024 AND BUSINESS UPDATE

Jul 4 09:58 ET

CARDIOFLOW-B: SIXTH AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION

Jun 26 10:31 ET

CARDIOFLOW-B: POLL RESULTS OF ANNUAL GENERAL MEETINGHELD ON JUNE 26, 2024

Jun 26 10:25 ET

CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 6 05:39 ET

CARDIOFLOW-B: FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 26, 2024

May 31 06:18 ET

CARDIOFLOW-B: NOTICE OF ANNUAL GENERAL MEETING

May 31 06:14 ET

CARDIOFLOW-B: (1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASESHARES (EXCLUDING TREASURY SHARES) AND TO ISSUE NEW SHARES(INCLUDING SALE OR TRANSFER OF TREASURY SHARES);(2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS;(3) PROPOSED RE-APPOINTMENT OF AUDITOR;

May 31 06:10 ET

CARDIOFLOW-B: VOLUNTARY ANNOUNCEMENT - ALTAVALVE WAS GRANTED THE BREAKTHROUGH DEVICE DESIGNATION BY THE FDA

May 9 10:36 ET

CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 7 07:23 ET

CARDIOFLOW-B: 2023 Annual Report

Apr 26 04:39 ET

CARDIOFLOW-B: VOLUNTARY ANNOUNCEMENT - CE MARK APPROVAL OF VITAFLOW LIBERTY

Apr 25 10:05 ET

CARDIOFLOW-B: CONTINUING CONNECTED TRANSACTIONIN RELATION TO2024 MP CARDIOADVENT SERVICE PROCUREMENT FRAMEWORKAGREEMENT

Apr 15 05:59 ET

CARDIOFLOW-B: GRANT OF SHARE OPTIONS

Apr 8 10:45 ET

CARDIOFLOW-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 8 04:46 ET

CARDIOFLOW-B: PROPOSED AMENDMENTS TO THE MEMORANDUM ANDARTICLES OF ASSOCIATION

Mar 27 10:33 ET